JPH10512247A - 真菌細胞壁の形成を抑制する組成物及び方法 - Google Patents

真菌細胞壁の形成を抑制する組成物及び方法

Info

Publication number
JPH10512247A
JPH10512247A JP8521293A JP52129396A JPH10512247A JP H10512247 A JPH10512247 A JP H10512247A JP 8521293 A JP8521293 A JP 8521293A JP 52129396 A JP52129396 A JP 52129396A JP H10512247 A JPH10512247 A JP H10512247A
Authority
JP
Japan
Prior art keywords
enzyme
antifungal
compound
glucose
chitin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8521293A
Other languages
English (en)
Japanese (ja)
Inventor
コラー，ローマン
キャビブ，エンリコ
ジェイ スィルヴァーマン，サンフォード
ペトラコーヴァ，エヴァ
Original Assignee
アメリカン サイアナミド カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アメリカン サイアナミド カンパニー filed Critical アメリカン サイアナミド カンパニー
Publication of JPH10512247A publication Critical patent/JPH10512247A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
JP8521293A 1995-01-04 1996-01-02 真菌細胞壁の形成を抑制する組成物及び方法 Pending JPH10512247A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36859195A 1995-01-04 1995-01-04
US08/368,591 1995-01-04
PCT/US1996/000752 WO1996020717A1 (en) 1995-01-04 1996-01-02 Compositions and methods for inhibiting fungal cell wall formation

Publications (1)

Publication Number Publication Date
JPH10512247A true JPH10512247A (ja) 1998-11-24

Family

ID=23451877

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8521293A Pending JPH10512247A (ja) 1995-01-04 1996-01-02 真菌細胞壁の形成を抑制する組成物及び方法

Country Status (5)

Country Link
EP (1) EP0796101A4 (de)
JP (1) JPH10512247A (de)
AU (1) AU702725B2 (de)
CA (1) CA2209663A1 (de)
WO (1) WO1996020717A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001051672A (ja) 1999-08-05 2001-02-23 Neucore Technol Inc 画像処理装置
CN110387364B (zh) * 2019-08-05 2023-09-01 河北农业大学 一种重组几丁质酶及其相关生物材料与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261264A (en) * 1984-11-29 1989-09-26 Shigeo Suzuki Immunopotentiating agents and method
US5030619A (en) * 1990-04-16 1991-07-09 Miles Inc. Synergistic fungicidal composition
JP3063930B2 (ja) * 1991-01-31 2000-07-12 味の素株式会社 アロサミジン化合物及びその製造法
US5326561A (en) * 1992-12-15 1994-07-05 Cornell Research Foundation, Inc. Antifungal synergistic combination of enzyme fungicide and non-enzymatic fungicide and use thereof

Also Published As

Publication number Publication date
AU4964496A (en) 1996-07-24
AU702725B2 (en) 1999-03-04
EP0796101A1 (de) 1997-09-24
EP0796101A4 (de) 2000-10-11
CA2209663A1 (en) 1996-07-11
WO1996020717A1 (en) 1996-07-11

Similar Documents

Publication Publication Date Title
Sun et al. Chemical structure and anti-inflammatory activity of a branched polysaccharide isolated from Phellinus baumii
Kollár et al. Architecture of the yeast cell wall: The linkage between chitin and β (1→ 3)-glucan (∗)
Miao et al. Structural elucidation and activities of Cordyceps militaris-derived polysaccharides: A review
Leitão et al. β-Galactofuranose-containing O-linked oligosaccharides present in the cell wall peptidogalactomannan of Aspergillus fumigatus contain immunodominant epitopes
Shibata et al. Immunochemistry of pathogenic yeast, Candida species, focusing on mannan
EP2283358B1 (de) Immunmodulierende zusammensetzungen und verfahren zu ihrer verwendung
Shibata et al. Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms
Yin et al. Arabinofuranosides from mycobacteria: synthesis of a highly branched hexasaccharide and related fragments containing β-arabinofuranosyl residues
Paramonov et al. Structural analysis of a novel anionic polysaccharide from Porphyromonas gingivalis strain W50 related to Arg‐gingipain glycans
Toledo et al. Characterization of sphingolipids from mycopathogens: factors correlating with expression of 2-hydroxy fatty acyl (E)-Δ3-unsaturation in cerebrosides of Paracoccidioides brasiliensis and Aspergillus fumigatus
Kong et al. An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep 2 Kdo 2
Levery et al. Structure elucidation of sphingolipids from the mycopathogen Paracoccidioides brasiliensis: an immunodominant β-galactofuranose residue is carried by a novel glycosylinositol phosphorylceramide antigen
US5952313A (en) LPS antagonists and methods of making and using the same
Silipo et al. The complete structure and pro‐inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram‐negative bacterium Burkholderia cenocepacia ET‐12 (strain J2315)
Forsberg et al. Localization and structural analysis of a conserved pyruvylated epitope in Bacillus anthracis secondary cell wall polysaccharides and characterization of the galactose-deficient wall polysaccharide from avirulent B. anthracis CDC 684
Chiovitti et al. VARIATIONS IN THE SUBSTITUTED 3‐LINKED MANNANS CLOSELY ASSOCIATED WITH THE SILICIFIED WALLS OF DIATOMS 1
Takahashi et al. Significant differences in the cell‐wall mannans from three Candida glabrata strains correlate with antifungal drug sensitivity
Rajput et al. Concise synthesis of a pentasaccharide related to the anti-leishmanial triterpenoid saponin isolated from Maesa balansae
Heise et al. Molecular analysis of a novel family of complex glycoinositolphosphoryl ceramides from Cryptococcus neoformans: structural differences between encapsulated and acapsular yeast forms
Shibata et al. The cell wall galactomannan antigen from Malassezia furfur and Malassezia pachydermatis contains β-1, 6-linked linear galactofuranosyl residues and its detection has diagnostic potential
Karki et al. An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer− arms
Nejatie et al. Kinetic and structural characterization of sialidases (Kdnases) from ascomycete fungal pathogens
Wang et al. Structure analysis and in vitro evaluation of probiotic properties for polysaccharides from Phellinus baumii extracted with phosphotungstic acid assistance
Shibata et al. Chemical structure of β-galactofuranose-containing polysaccharide and O-linked oligosaccharides obtained from the cell wall of pathogenic dematiaceous fungus Fonsecaea pedrosoi
Chinoy et al. Chemical synthesis of a glycopeptide derived from Skp1 for probing protein specific glycosylation